Understanding the Effects of Aspirin

Aspirin, also known as acetylsalicylic acid, is a common medication used for several purposes. It belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Aspirin works primarily by inhibiting enzymes called cyclooxygenases (COX-1 and COX-2), which are involved in the synthesis of prostaglandins and thromboxanes.

Let's look at the options provided and see which one is not an effect of aspirin:

• Reduction of fever: Aspirin has antipyretic properties, meaning it helps reduce fever. This effect is due to its inhibition of prostaglandin synthesis in the hypothalamus, the part of the brain that regulates body temperature. So, reduction of fever is an effect of aspirin.
• Reduction of prostaglandin synthesis in inflamed tissues: Aspirin significantly reduces the synthesis of prostaglandins. Prostaglandins contribute to inflammation, pain, and fever. By inhibiting their production, aspirin exerts its anti-inflammatory, analgesic (pain-relieving), and antipyretic effects. This is a core mechanism of aspirin's action, so reduction of prostaglandin synthesis is an effect of aspirin.
• Impaired auto regulation of kidney function: Prostaglandins play a role in maintaining kidney blood flow, especially when kidney function is already compromised. By inhibiting prostaglandin synthesis, especially COX-1 mediated synthesis, aspirin (and other NSAIDs) can impair the kidney's ability to regulate its blood flow and function, potentially leading to kidney problems, particularly with long-term use or in vulnerable individuals. Therefore, impaired auto regulation of kidney function can be a side effect or effect of aspirin, especially under certain conditions.
• Reduction of bleeding tendency: This is where aspirin has a notable effect, but it's the opposite of reduction. Aspirin inhibits the synthesis of thromboxane A2 (TXA2) in platelets. TXA2 is a substance that promotes platelet aggregation (clumping together) and vasoconstriction (narrowing of blood vessels). By inhibiting TXA2 production, aspirin prevents platelets from clumping together effectively, which increases bleeding tendency and prolongs bleeding time. This is why aspirin is sometimes used in low doses to prevent blood clots in individuals at risk of heart attack or stroke. Thus, reduction of bleeding tendency is not an effect of aspirin; instead, it increases bleeding tendency.

Based on the analysis, the reduction of bleeding tendency is not an effect of aspirin. Aspirin actually increases bleeding tendency by inhibiting platelet aggregation.